Background
Behcet disease is a rare disorder characterized by recurrent oral and genital ulceration, eye lesions, and multiple skin lesions. The first modern description was in the 1930s by a Turkish dermatologist, Hulusi Behcet, who noted the triad of aphthous oral ulcers, genital lesions, and recurrent eye inflammation. A recent consensus conference identified several criteria to establish the diagnosis. Some of these parameters include:
Mucocutaneous lesions (oral ulcers-recurrent, at least three times per year)
Patients must also meet two of the following four criteria:
Recurrent genital ulcerations
Eye lesions (uveitis or retinal vasculitis)
Positive pathergy test (trauma induced lesions)
Skin lesions as diagnostic of Behcet's diseaseThe skin lesions range from leukocytoclastic vasculitis, pustular dermatitis, and clinical lesions resembling Sweet's syndrome, pyoderma gangrenosum, and erythema nodosum. Some investigators believe only cutaneous lesions containing infiltrates of neutrophils around blood vessels is diagnostic.
This disease is characterized by recurrence and relapse. Like many vasculitides, this disease may affect multiple organs. See the outline below for a detailed discussion.
OUTLINE
DISEASE ASSOCIATIONS CHARACTERIZATION Familial cases Rare, <5% of cases
LABORATORY/
RADIOLOGYCHARACTERIZATION RADIOLOGY MRI Arthropathy in Behcet Disease: MR Imaging Findings in Two Cases.
Choi JA, Kim JE, Koh SH, Chung HW, Kang HS.
Department of Radiology, Seoul National University College of Medicine, 28 Yongon-dong, Chongno-gu, Seoul 110-744, Korea. Received December 4, 2001.
Radiology 2003 Feb;226(2):387-9 Abstract quote Arthropathy is part of the protean manifestations of Behcet disease. Imaging findings reported thus far have been based on those of conventional radiography.
Magnetic resonance imaging in two cases of Behcet disease with arthropathy demonstrated synovial thickening and effusion, as well as myositis manifested by high signal intensity on T2-weighted images.
SPECT
Decreased cerebral blood flow in neuro-Behcet's syndrome patients with neuropsychiatric manifestations and normal magnetic resonance imaging--a preliminary report.Huang WS, Chiu PY, Kao A, Tsai CH, Lee CC.
Department of Neurology, China Medical College Hospital, No 2, Yuh-Der Road, Taichung 404, Taiwan, ROC.
J Neuroimaging 2002 Oct;12(4):355-9 Abstract quote Involvement of the brain is one of the most important complications of Behcet's disease, but its diagnosis is difficult because of the lack of effective imaging tools.
Therefore, technetium-99m ethyl cysteinate dimer (Tc-99m ECD) single-photon emission computed tomography (SPECT) of the brain was used to detect abnormal regional cerebral blood flow in patients with neuro-Behcet's syndrome (NBS). Tc-99m ECD brain SPECT was performed to detect hypoperfusion areas of the brain in 10 NBS patients with definite neuropsychiatric symptoms or signs and normal brain magnetic resonance imaging (MRI) findings. Tc-99m ECD brain SPECT demonstrated hypoperfusion areas of the brain in all of the 10 NBS patients.
The parietal lobes were the most common areas with hypoperfusion lesions. Tc-99m ECD brain SPECT is a more sensitive and useful tool than brain MRI for detecting hypoperfusion areas of the brain in NBS patients.
LABORATORY SERUM CYTOKINES
Cytokine profile in Behcet's disease patients. Relationship with disease activity.Hamzaoui K, Hamzaoui A, Guemira F, Bessioud M, Hamza M, Ayed K.
Scand J Rheumatol 2002;31(4):205-10 Abstract quote OBJECTIVE: To analyse proinflammatory Th1 and Th2 cytokines in patients with Behcet's disease (BD) in relation to disease activity.
METHODS: Forty-five BD patients (25 in active stage) were investigated with ELISA for estimation of cytokines levels. Furthermore, cytokines intracellular synthesis (IL-4 and IFN-gamma) of CD4+ T cells was studied.
RESULTS: Active and in remission BD patients showed increased serum levels of Th1 (IFN-gamma, IL-12) and Th2 (IL-4, IL-6 and IL-10) cytokines. Active BD was characterized by a higher increase of IL-6, IL-10 and a striking increase of IL-17, IL-18 and IFN-gamma, compared to remission RD. Upon in vitro stimulation, the percentages of CD4+ T cells containing IFN-gamma and CD40L were higher in active BD compared to healthy controls.
CONCLUSION: Our results suggest that the microenvironment of CD4+ T cells in active BD may induce the production of more cells committed to Th1 than in BD patients in remission and healthy controls.
GROSS APPEARANCE/
CLINICAL VARIANTSCHARACTERIZATION VARIANTS Central nervous system White matter lesions with in brain and brainstem leading to headaches, confusion, strokes, personality changes, and dementia in rare cases
Aseptic meningitis
Eye Anterior uveitis or posterior uveitis Genitals Painful deep scrotal lesions
Painful vulvar lesionsGastointestinal tract Ulcerations throughout the tract favoring the terminal ileum and cecum
May clinically mimic inflammatory bowel disease, especially Crohn's disease
HEART/AORTA
Cardiac Behçet Disease Presenting as Aortic Valvulitis/Aortitis or Right Heart Inflammatory Mass: A Clinicopathologic Study of 12 Cases.Departments of *Pathology †Internal Medicine, Division of Cardiology ‡Division of Immunology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
Am J Surg Pathol. 2008 March 32(3);390-398 Abstract quote
Behçet disease is an inflammatory disorder of unknown etiology showing diverse clinical presentations. Cardiac involvement is a critical problem that requires a timely diagnosis and management. However, clinicopathologic features have not been characterized clearly.
Here, we present clinicopathologic characteristics of this uncommon disease. Patients included 8 males and 4 females, ranging from 24 to 52 years old. They were presented with abrupt heart failure and were mostly diagnosed as having cardiac Behçet disease later in the course. Upon echocardiography, 8 patients showed severe aortic regurgitation with redundant prolapsing aortic cusps and 4 patients showed irregular mass lesions in the right ventricular cavity. No one had both lesions. The aortic root was also involved with aortic valvulitis, showing severe mixed acute and chronic inflammation of various stages. There were frequent microabscess and extensive endothelial loss with fibrinous deposit. The right heart lesions showed similar histopathologic features. Four patients who initially underwent simple aortic valve replacement developed serious postoperative complications requiring reoperations. No serious complications developed after the treatment was changed to a replacement of aortic root with extensive debridement and concomitant immunosuppressive therapy.
Cardiac Behçet disease is presented as aortic valvulitis/aortitis or inflammatory mass lesion. Characteristic echocardiographic and pathologic findings seem to be helpful for the timely diagnosis of this critical disease.Joints Arthritis Lung Aneurysms of arteries in the lung which may rupture leading to massive lung hemorrhage Mouth Aphtous ulcers-painful sores in the mouth More numerous, more frequent, more painful, and larger than cases in the general population
Lips, tongue, and inside of the cheek.
Occur in virtually all patients with Behcet’s
HISTOLOGICAL TYPES CHARACTERIZATION General A vasculitis may be present in lesional organs VARIANTS Erythema nodosum-like lesions Am J Dermatopathol 2000;22:379-390
Panniculitis in a lobular or mixed septal lobular pattern
Neutrophils present in all lesions and in all stages of the disease and usually confined to the areas of fat necrosis or around inflammed vesselsVasculitis either leukocytoclastic or lymphocytic with some occurring in same specimen in different vessels
Clinicopathologic Evaluation of Nodular Cutaneous Lesions of Behçet Syndrome
Cuyan Demirkesen, MD
Nükhet Tüzüner, MD
Cem Mat, MD
Mustafa Senocak, PhD
Nesimi Büyükbabani, MD
Yalçin Tüzün, MD
Hasan Yazici, MDAm J Clin Pathol 2001;116:341-346 Abstract quote
Among the cutaneous manifestations, nodular lesions are rather common in Behçet syndrome. The histologic nature of these lesions has been a matter of controversy.
To establish their distinguishing features, biopsy specimens from nodular lesions of 24 patients with Behçet syndrome, 25 with nodular vasculitis (NV), and 20 with erythema nodosum (EN) were compared. Statistical analysis revealed insignificant differences between most of the histologic features of Behçet syndrome and NV. However, neutrophil-predominating infiltrate in the subcutis was more common in Behçet syndrome, while necrosis and granuloma formation were encountered more frequently in NV. The differences between Behçet syndrome and EN were more significant. Septal panniculitis, lymphocyte-predominating infiltrate, absence of many vascular changes as well as vasculitis, and necrosis were features in favor of EN.
Nodular lesions of Behçet syndrome are mainly neutrophilic vascular reactions with histologic features similar to NV but significantly differing from EN associated with other systemic diseases.
SPECIAL STAINS/
IMMUNOPEROXIDASECHARACTERIZATION GENERAL
Immunohistology of oral lesions from patients with recurrent oral ulcers and Behcet's syndrome.Poulter LW, Lehner T.
Department of Immunology, Royal Free Hospital and School of Medicine, London, England.
Clin Exp Immunol 1989 Nov;78(2):189-95 Abstract quote A qualitative and quantitative immunohistological investigation was performed on biopsies of oral ulcers from patients with Behcet's syndrome (BS) and those with recurrent oral ulcers (ROU). The results were compared with control oral biopsies from patients with other diseases and normal oral mucosa. The expression of HLA-DR on the cell membrane of keratinocytes was found in 13 out of 15 lesions from patients with BS and ROU, as compared with only one out of 15 controls.
The relative density of HLA-DR was investigated quantitatively by microdensitometry and this confirmed that DR expression in the epithelial cells of patients with BS and ROU was significantly greater than in diseased and normal control oral tissues. A prominent mononuclear cell infiltration consisted predominantly of T lymphocytes and mature macrophages. Analysis of the CD4 and CD8 subsets of T cells failed to show significant differences between BS, ROU and control diseased tissues. Increased numbers of Langerhans cells were found in the epithelium by morphometric analysis with the CD1 monoclonal antibody in BS and ROU but an increased number was also found in lichen planus.
The results suggest that the immunohistological changes in oral lesions of BS and ROU manifest an enhanced immune response in the epithelium, keratinocytes express HLA-class II antigen and increased number of Langerhans cells as well as in the lamina propria with a prominent infiltration of CD4, CD8 and macrophage-like cells.
The characteristic pattern of exacerbations and remissions of oral ulceration can be interpreted by the hypothesis that an initiating microbial agent may induce a mononuclear cell infiltration, with the release of cytokines, expression of class II antigen in keratinocytes and causing ulceration, followed by down-regulation of immunity by tolerant T cells induced by the class II positive keratinocytes, leading to a remission.
DIFFERENTIAL DIAGNOSIS KEY DIFFERENTIATING FEATURES APHTHOUS ULCERS
- Complex aphthosis: a large case series with evaluation algorithm and therapeutic ladder from topicals to thalidomide.
Letsinger JA, McCarty MA, Jorizzo JL.
Department of Dermatology at University of California, San Fransico, CA 94118, USA.
J Am Acad Dermatol. 2005 Mar;52(3 Pt 1):500-8. Abstract quote
BACKGROUND: Recurrent aphthous stomatitis is a common problem with 20% to 50% of the population having experienced simple aphthous lesions (ie, canker sores). Complex aphthosis is the diagnosis given to patients with almost constant >3 oral aphthae or recurrent oral and genital aphthae in the absence of Behcet's disease.
METHODS: Eighty-one patients were referred to the Wake Forest University School of Medicine, Department of Dermatology from 1995 to 2001 with the diagnosis of presumptive Behcet's disease. After exclusion of patients with simple recurrent aphthous stomatitis or non-aphthous oral disease, 64 patients remained. Ten of the patients met criteria for Behcet's disease. The remaining 54 patients were evaluated and treated as patients with the diagnosis of complex aphthosis.
RESULTS: The 54 patients with complex aphthosis became the subject of this study. Twelve patients had secondary complex aphthosis with 10/12 having inflammatory bowel disease. The remaining 42 patients had primary (ie, idiopathic) complex aphthosis. The therapeutic ladder for these patients ranged from topical therapy through oral colchicine and combination oral colchicine and oral dapsone therapy to oral thalidomide therapy.
CONCLUSION: Complex aphthosis is an important condition to distinguish from Behcet's disease. Appropriate patient evaluation algorithms and treatment therapeutic ladders are proposed.Erythema nodosum Neutrophils present only in early lesions
Predominately a septal panniculitis
PROGNOSIS AND TREATMENT CHARACTERIZATION TREATMENT Colchicine, cyclophosphamide and steroids for eye involvement
Azapropazone and colchicine for arthritis
Acyclovir, colchicine and topical interpheron for aphthous ulcers
In general, there are protective effects of cyclosporine and azathioprine for eye involvement and benzathine-penicillin for arthritis
INTERFERON-ALPHA Interferon alfa combined with azathioprine for the uveitis of Behcet's disease: an open study.
Hamuryudan V, Ozyazgan Y, Fresko Y, Mat C, Yurdakul S, Yazici H.
Behcet's Syndrome Research Center, Cerrahpaa Medical Faculty, University of Istanbul, Istanbul, Turkey.
Isr Med Assoc J 2002 Nov;4(11 Suppl):928-30 Abstract quote BACKGROUND: Eye involvement is the main cause of morbidity in Behcet's syndrome. The efficacy of the combined use of azathioprine and interferon alfa in treating this condition has not been studied.
METHODS: Ten male BD patients with retinal involvement but no irreversible structural changes were treated with azathioprine 2.5 mg/kg/day and IFN alpha 2b three times weekly for 24 weeks in an open trial. At week 24, IFN alpha was stopped and the patients continued to use azathioprine or received other immunosuppressives as indicated. Clinical response was assessed by visual acuity changes of either eye under the combination treatment and during the follow-up after stopping interferon.
RESULTS: As compared to the study entry, the mean visual acuities of either eye increased significantly at the end of the combination treatment (right eye 5.8 +/- 1.26 vs. 8.3 1.14; P = 0.043; left eye 6.3 1.15 SEM vs. 9.1 +/- 0.9 SEM; P = 0.027). The improvement in visual acuity persisted in the nine patients who were followed for 7.2 +/- 1.6 SEM months after stopping interferon. Reversible hematologic toxicity, mostly in the form of leukopenia, was detected in six patients during the combination treatment.
CONCLUSIONS: The combination of IFN alpha and azathioprine appears to be effective for eye involvement of BD. However, the frequent occurrence of myelosuppression mandates close monitoring.
Interferon Alfa-2a in the Treatment of Behcet Disease: A Randomized Placebo-Controlled and Double-blind Study.Alpsoy E, Durusoy C, Yilmaz E, Ozgurel Y, Ermis O, Yazar S, Basaran E.
Department of Dermatology, Akdeniz University School of Medicine, 07070 Antalya, Turkey.
Arch Dermatol 2002 Apr;138(4):467-71 Abstract quote OBJECTIVE: To determine the therapeutic efficacy of interferon alfa-2a in the treatment of Behcet disease.
DESIGN: A randomized placebo-controlled and double-blind study.
SETTING: University referral center.
PATIENTS: Fifty patients with Behcet disease were involved in the study.
INTERVENTION: The patients were given interferon alfa-2a, 6 x 10(6) IU, subcutaneously 3 times per week or placebo for 3 months, and examined clinically at weekly intervals.
MAIN OUTCOME MEASURES: For each mucocutaneous lesion and articular symptom, the mean frequency and duration were evaluated during the 3-month pretreatment, treatment, and follow-up periods. Pain for oral and genital ulcers was scored on a scale of 0 to 3. The ocular inflammatory score, the frequency of attacks, and changes in visual acuities for patients with ocular involvement were assessed before the study, at the end of treatment, and during the follow-up periods. In addition, overall responses at the end of the treatment period were graded as follows: complete remission, disappearance of all clinical signs and symptoms during treatment; partial remission, greater than a 50% decrease in the frequency, duration, and severity of pain for oral and genital ulcers and/or a decrease in the severity and frequency of ocular attacks; stable disease, less than a 50% change in the clinical signs and symptoms; and no effect or deterioration, ineffectiveness or worsening of clinical signs and symptoms.
RESULTS: Twenty-three interferon alfa-2a- and 21 placebo-treated patients, ranging in age from 16 to 55 years (mean +/- SD age, 32.38 +/- 7.94 years), were evaluable for efficacy. Interferon alfa-2a treatment significantly decreased the duration (P=.02) and pain (P=.01) of oral ulcers and the frequency of genital ulcers (P=.03) and papulopustular lesions (P=.01). The mean frequency and duration of erythema nodosum-like lesions (P=.77 and.27, respectively), thrombophlebitis (P=.29 and.61, respectively), and articular symptoms (P=.92 and.74, respectively) also decreased. But there were no statistically significant differences. An improvement in the severity and the frequency of ocular attacks occurred in 5 of 6 patients in the interferon alfa-2a-treated group and in 1 of 3 patients in the placebo-treated group. Of the 23 patients in the interferon alfa-2a-treated group, 15 responded to treatment (2 complete and 13 partial responses); and of the 21 patients in the placebo group, 3 responded to treatment (3 partial responses) (P<.005).
CONCLUSION: Interferon alfa-2a is an effective alternative treatment for Behcet disease, particularly for the management of the mucocutaneous lesions of the disease.
Thalidomide May be effective in the treatment of mucocutaneous Behcets disease
Effectiveness in more severe Behcets disease, however, is not known
Macpherson and Pincus. Clinical Diagnosis and Management by Laboratory Methods. Twentyfirst Edition. WB Saunders. 2006.
Rosai J. Ackerman's Surgical Pathology. Ninth Edition. Mosby 2004.
Sternberg S. Diagnostic Surgical Pathology. Fourth Edition. Lipincott Williams and Wilkins 2004.
Robbins Pathologic Basis of Disease. Seventh Edition. WB Saunders 2005.
DeMay RM. The Art and Science of Cytopathology. Volume 1 and 2. ASCP Press. 1996.
Weedon D. Weedon's Skin Pathology Second Edition. Churchill Livingstone. 2002
Fitzpatrick's Dermatology in General Medicine. 6th Edition. McGraw-Hill. 2003.
Weiss SW and Goldblum JR. Enzinger and Weiss's Soft Tissue Tumors. Fifth Edition. Mosby Elesevier 2008
Pathergy Test-The forearm is pricked with a small, sterile needle. The occurrence of a small red bump or pustule at the site of needle insertion is a positive test. Only a minority of Behcets patients demonstrate the pathergy phenomenon. Mediterranean patients are more likely to demonstrate pathergy. Other conditions can occasionally result in positive pathergy tests.
Basic Principles of Disease
Learn the basic disease classifications of cancers, infections, and inflammation
Commonly Used Terms
This is a glossary of terms often found in a pathology report.Diagnostic Process
Learn how a pathologist makes a diagnosis using a microscopeSurgical Pathology Report
Examine an actual biopsy report to understand what each section meansSpecial Stains
Understand the tools the pathologist utilizes to aid in the diagnosisHow Accurate is My Report?
Pathologists actively oversee every area of the laboratory to ensure your report is accurateGot Path?
Recent teaching cases and lectures presented in conferences
Last Updated March 10, 2008
Send mail to The Doctor's Doctor with questions or comments about this web site.
Read the Medical Disclaimer.
Copyright © The Doctor's Doctor